KLK3 and prostate cancer: As this novel parameter was designed for a substitute to conventional parameters representing prostate oncological hazards, our performance analysis included two functions of conventional clinical PSA measurement: detection of the presence of prostate cancer in screening and definition of the oncological status of prostate cancer patients before definitive treatment.